Mumbai, March 28, 2019: Nutricia International Pvt Ltd (Danone India), with its mission ‘to bring health through food to as many people as possible’, elevated Himanshu Bakshi as Managing Director of its India operations effective 1st April 2019. With more than 19 years of experience in Marketing and Sales, Himanshu joined Danone as Marketing Director in 2013 and was tasked with leading the marketing and sales portfolio of the company. In his new role, Himanshu will be responsible for steering the company into its next phase of growth, as a leading nutrition company.
Commenting on the new role, Himanshu Bakshi, Managing Director, Danone India said “I am grateful for the expansion in my responsibilities and look forward to lead the enthusiastic and dynamic team at Danone in the next phase of transformation as we establish ourselves in India as a leading Nutrition company responding to local needs. Danone has a unique vision of bringing health through food to consumers, and I am excited to deliver this promise to consumers through our unique portfolio of Indian and global products”.
Himanshu began his career with Dabur and moved to Pepsi. He started his Brand Marketing journey with Reckitt Benckiser responsible for marketing of brands like Lizol and Dettol followed by Danone where he handled various responsibilities in marketing and sales. Under his leadership, Protinex started its trajectory to become a consumer facing brand with key initiatives to forge awareness around protein relevance.
Dedicated to bringing health through food to as many people as possible, Danone is a leading global food company with sales of approximately €24.7 billion in 2018 and a presence in over 120 markets. In India, Danone started its nutrition business in 2012 through the acquisition of the nutrition portfolio from Wockhardt Group. Danone India offers a range of specialized products across life stages that includes pregnancy, infants, young children as well as adults, under recognized Indian and global brands like Aptamil, Neocate, Farex, Protinex, Dexolac and Nusobee.
For more details please contact: